International arbitration

We represented a subsidiary of an Algerian company in an ICC arbitration initiated as a claimant against French, Malaysian, and Singaporean companies. The dispute arose from the conclusion and execution of a joint venture agreement for the design, construction, maintenance, and operation of a desalination plant in Algeria.

We supported a leading French biotechnology company specializing in rodent engineering for fundamental, preclinical, and clinical research in its dispute against a Chinese company supplying custom-designed mouse and rat models. The two companies concluded a license and distribution agreement in 2019, aiming to grant the Chinese company a license to breed and commercialize genetically modified mouse lines designed and supplied by our client in APAC countries. Due to serious violations of this agreement by the Chinese company, our client initiated an ICC arbitration seated in Singapore in May 2022. The arbitration is ongoing, and a hearing was held at the end of 2023.

We represented two British companies in an ICC post-closing Merger and Acquisition arbitration procedure against a French company. The dispute arose from the French company’s compensation claims regarding the alleged liability of the two British companies in compensating asbestos-related claims.

We represented our Chinese and Congolese (DRC) clients against an Australian and a British company in an ICC arbitration arising from violations of a co-enterprise agreement (concerning the world’s largest lithium extraction project). The arbitration allowed the claimants to terminate the co-enterprise agreement. In the arbitration claim, the plaintiffs are seeking damages and interest amounting to USD 850 million and USD 566 million for our Chinese and Congolese (DRC) clients, respectively.

We assisted an Algerian company in a formal notice procedure initiated by French and Malaysian companies against a partial ICC award on jurisdiction and admissibility.